Member Info for ShareSting

JBER is now off the offer.
The shape on L2 has changed a bit. Maybe we might see some blue soon.

Just 1hr ago they posted about Synairgen and the inhaled asthma drug can be used as part of a clinical trial to treat hospitalised Covid19 patients is backed by NIHRresearch

Trials are ongoing. They wouldn’t be tweeting if not.

Relax and let’s see what happens. Bring on the At Home Trials.

Some newbies might have missed Richards comments from two weeks back. This is not a share for day traders it’s a share for investors.

There are plenty of stocks being pumped by the normal names on Twitter. I am personally glad SNG is being kept out of that lane.

If people want to sell, go. If people want to be negative back it up. This board can be so informative some days and quite shocking others.

For me no news is good news. My holding is swinging in all over the place, one week a paper gain of £15k the next a paper loss.

I believe in this company and Management.

I am here for the journey. If you want to play elsewhere, go for it just please don’t spam this board. There are some real quality posters with valuable research.

Cheers all

Just imagine how huge a prevention treatment would be.
It doesn’t stop Covid19, that would take a vaccine, but it does prevent it at worst limit the number of high risk entering hospital.

We know SNG has a model for this trial already. If treating high risk in first signs of cough, fever, joint pain... works as well as it is against COPD, this would be a complete game changer.

Bring on the RNS Richard !!

Morning all.
That was an interesting report last night. Out of 12188 tested 25% had asthma or COPD.

I can’t wait for the RNS that confirms the AT HOME trials have started.

As for the share price. One thing Richard has said from the start “ this is no share for day traders”.

I have been doing some research into what value drugs sell for. It is quite outstanding. Early stage development with positive signs is around £250m. Step this up to have full approval could be £1 billion up to £10 billion dependent on the size of the market. Quite staggering.

Let’s hope Richard can get SNG001 approved and we could be looking at billions not millions. This is fact no ramping. If I’m doubt do your own research before you take a cheap shot at me.

Other = 4113
Chronic Cardic Disease = 2878
DIABETES = 2022
Chronic Pulmonary Disease = 1712
Asthma = 1416
Kidney Disease = 1408
Obesity = 1077
Dementia = 1036

Out of a total 12188 reviewed = 3128 had chronic pulmonary disease and or asthma. 25%

Sorry report
https://8b7299ce-6228-4f56-a915-2a5366571543.usrfiles.com/ugd/8b7299_3568274b721641e395af120090584e37.pdf

This report is very interesting to understand Covid19.
Best way is to head to the end and it ranks symptoms ...
not so important for SNG. But useful !
Interesting to see Asthma featuring quite high !

Most people posting here have genuine intentions. Posts are based on CEO Interviews, CEO direct emails, previous clinical studies, new and old publications on Interferon, company RNS’s and live trade information.

Our posts and in fact our investments are based on this be it £1000 or £100,000. We can’t be judged as trolls or rampers if we are questioning genuine data, like this weekend. All we can do is search for answers.

Luckily for us Richard is available to answer non market sensitive sensible questions. This is good given the pressure the team are under.

Other more generic questions and comments are also based on the above data. My big question is around home trials. As if successful this could open up a new market, save lives and at billions in value to the business.

So I personally thank all the constructive and critically constructive posts and questions. I have no time for spammers rampers and trolls.

Thank you again to Miggy and many others on here for all your time research and genuine commitment to Synairgen!

It makes a huge difference.

I believe Richard is in constant communication with regulators to ensure a proactive response to any questions/ concerns. Anyone judging Covid19 clinical studies against “traditional” clinical studies is simply misguided.

As for the at home trials, I believe this will be a separate trial which will NOT hold up any decisions made by MHRA and FDA.

I take it you are not being serious!

And the 30k buy at 1331 !!

Puntin you need to give the buyer more time to accumulate
For example the 25k buy at 13.29 I doubt is a PI.
These trades have been all day, week, month.
First we had the distressed seller, then the placing shares. I do wish Richard had made them sticky with a lock-in. But heyho the churn continues and the seller will feed the buyer. PI’s need to remain calm whilst this happens.

Yes Miggy confirmed.
I’m happy with the response.

The drug has been in Clinical trials for COPD for the last 12+ months. This data will be combined with the Covid19 data for regulatory application. Is it safe to use ? Does it work and if so how and with who ? (Basics).

Any investment on AIM is high risk. I have never researched a share as much as I have Synairgen. I liked their work on COPD and this is worth over £1 per share alone. Remember this company was hit by Woodford.

I am happy and relaxed. If you are not, I suggest you reduce your holding until you reach a point you are.

This is such a unique and exciting time for shareholders and the employees / consultants at SNG. We all have one thing in common. Let’s make SNG001 a success !

I expect we will hear more leaks from patients soon !

Miggy nothing price sensitive in there. Richard is keen to keep communications open with shareholders as he recognises our loyalty. He is also very strict and will not share anything price sensitive.
I asked him a question about nebuliser partnership and a different question on ongoing regulatory discussions. Both he could answer without making me an insider. No thanks I want to buy more when funds allow.

Miggy
Likewise I thanked Richard. I also asked about the opportunity for SNG to participate in the Impulse GP trials or potentially set up our own trials in care homes.

Richard said any at additional at home trials would be communicated via RNS.

Miggy
I received the same email. It looks like we share the same first name !

Roto the lack of news ?
Did you watch the video last week featuring Richard ?
There is huge, massive, quantis amounts of data being logged at the moment. The company is working non stop to prepare for me regulatory application.
We are awaiting an update on Home trials, but this takes time to establish the required protocols for approval.

This is huge guys and will take time to implement.

Duster someone is buying !
IMO this will be bought out. So if a company can slowly acquire shares at this level before placing a bid, why wouldn’t they. As long as they continue to buy there is no need to TR1 as thresholds are crossed.

It’s also clear the 10k seller is keeping the price at a level around 60p.

These games will continue as long as MM’s allow them.